Top Marijuana Penny Stocks to Watch in May 2026
The cannabis sector continues attracting traders looking for high-upside opportunities in 2026. Although the market remains volatile, many marijuana penny stocks still show strong long-term potential. Several cannabis companies continue to expand operations while awaiting possible federal reform. In addition, more states continue to support medical and adult-use legalization. This has helped keep investor interest alive despite recent sector weakness.
Marijuana penny stocks can move quickly during periods of strong momentum. However, these stocks also carry significant risk. Because of this, traders should continue using technical analysis and proper risk management. Watching support levels, volume, and market sentiment can help improve trade setups. With that in mind, here are three marijuana penny stocks that many investors continue to watch closely in May 2026.
[Read More] 3 Marijuana Stocks For Better Investing In 2026
Best Marijuana Penny Stocks for Watchlists in May 2026
- AYR Wellness Inc. (OTC: AYRWF)
- Cresco Labs Inc. (OTC: CRLBF)
- Verano Holdings Corp. (OTC: VRNOF)
AYR Wellness Inc. (AYRWF)
AYR Wellness remains one of the more recognizable multi-state cannabis operators in the United States. The company has built a strong presence across several major cannabis markets. Its largest operations remain in Florida and Pennsylvania. AYR also continues expanding in states like Ohio and New Jersey. The company operates more than 90 dispensaries throughout the country.
AYR focuses heavily on vertical integration. This means the company controls cultivation, processing, and retail operations. As a result, AYR can maintain stronger quality control and potentially improve margins over time. The company also owns several cannabis brands across multiple product categories. These include flower, concentrates, vapes, and edibles.
Florida remains one of AYR’s most important growth markets. The medical cannabis market there continues to expand steadily. Additionally, many investors continue to watch Florida closely because of potential adult-use opportunities. AYR has continued investing in its retail footprint while improving operational efficiency. The company has also focused on reducing costs during a difficult cannabis market environment.
AYRWF continues trading at penny-stock levels after a major weakness across the cannabis sector. However, many traders still monitor the stock for potential recovery opportunities. Strong reform headlines or positive sector momentum could quickly increase investor interest. Because of this, AYR remains one of the more actively watched marijuana penny stocks this year.
Latest Financials
On the financial side, AYR Wellness recently reported mixed results amid continued pricing pressure across the cannabis industry. Revenue remained relatively stable compared to previous periods. However, lower cannabis prices continued to impact profitability. The company also focused heavily on expense reductions and improving operational performance.
Management continues to prioritize cash preservation and debt restructuring efforts. These initiatives remain important because cannabis companies still face limited banking and financing options. AYR also worked to lower capital expenditures while maintaining core operations. This strategy could help improve long-term financial stability.
The company reported adjusted EBITDA, indicating some operational resilience despite industry challenges. Gross margins also remained fairly stable during recent quarters. Investors will continue to monitor liquidity levels and cash flow performance carefully moving forward. Additionally, many traders believe future cannabis reform could significantly improve sector valuations.
Although the stock remains speculative, AYR Wellness continues to offer strong exposure to several key cannabis markets. If sentiment improves across the sector, AYRWF could become one of the stronger recovery names to watch during 2026.
[Read More] Cannabis REITs Gaining Momentum in 2026: 3 Stocks to Watch
Cresco Labs Inc. (CRLBF)
Cresco Labs continues to rank among the most established cannabis operators in the United States. The company operates the Sunnyside dispensary brand across multiple states. Cresco has a particularly strong presence in Illinois, Pennsylvania, and Florida. In total, the company operates more than 70 dispensaries nationwide.
Cresco has built its reputation around strong wholesale operations and recognizable cannabis brands. Some of its better-known products include High Supply, FloraCal, and Good News. The company continues focusing heavily on branded product sales and market expansion. This strategy has helped Cresco remain competitive in several mature cannabis markets.
Illinois remains one of Cresco’s most important states. The company has maintained a strong market share there through both retail and wholesale operations. Cresco also continues benefiting from exposure to additional adult-use markets across the country. Investors often watch the company closely because of its national footprint and established brand portfolio.
CRLBF shares remain under pressure alongside the broader cannabis sector. However, many traders continue viewing the stock as a potential rebound candidate. The company’s scale and operational reach continue making it one of the better-known marijuana penny stocks available today. Additionally, future federal reform could create meaningful upside across the entire sector.
Latest Financials
Financially, Cresco Labs has continued focusing on operational efficiency and profitability improvements. Like many cannabis companies, Cresco has faced pricing compression across several states. Despite this, the company continues generating significant annual revenue through retail and wholesale cannabis sales.
Management has also focused heavily on reducing operating expenses and strengthening margins. These efforts remain important while the cannabis industry works through slower growth conditions. Cresco continues prioritizing free cash flow generation and disciplined spending. Investors continue watching adjusted EBITDA trends closely during each earnings report.
The company also maintains strong exposure to wholesale cannabis distribution. This gives Cresco an advantage over operators who rely mostly on retail sales. Additionally, Cresco continues to expand its product offerings while maintaining strong brand recognition in key states.
Many traders still believe Cresco Labs remains one of the stronger long-term cannabis operators. Although volatility remains high, the company continues showing resilience during a difficult market cycle. If broader cannabis sentiment improves, CRLBF could attract renewed buying momentum during 2026.
[Read More] Top Canadian Marijuana Stock Choices For Better Investing In 2026
Verano Holdings Corp. (VRNOF)
Verano Holdings continues to stand out as one of the larger cannabis companies operating in the United States. The company operates the Zen Leaf dispensary brand across several major markets. Verano maintains strong operations in Florida, Illinois, Maryland, and New Jersey. Overall, the company operates more than 130 dispensaries nationwide.
Verano has continued expanding its retail and cultivation footprint throughout the country. The company also owns several branded cannabis products across flower, edibles, concentrates, and vape categories. This diversified approach helps Verano compete across multiple consumer segments. Additionally, the company benefits from exposure to several growing adult-use cannabis states.
Florida remains one of Verano’s most important markets. The company continues to expand its retail operations there while building brand awareness. New Jersey and Maryland also remain important growth areas because of rising adult-use cannabis demand. Investors continue to monitor these states closely for future revenue growth opportunities.
VRNOF shares continue trading at relatively low levels compared to previous cannabis market highs. However, many traders still believe Verano could benefit from a broader sector recovery. The company’s large operational footprint and strong retail presence continue attracting investor attention. Furthermore, positive reform headlines could quickly improve momentum for stocks like Verano.
Latest Financials
From a financial perspective, Verano has continued focusing on profitability and operational discipline. The company recently reported relatively stable revenue despite difficult market conditions. Like other cannabis operators, Verano has faced pricing pressure in several states. However, management has worked to control expenses and improve efficiency.
The company also continues generating strong retail sales through its Zen Leaf dispensaries. Additionally, Verano maintains exposure to several high-growth cannabis markets. Investors continue watching adjusted EBITDA and cash flow metrics closely each quarter. These numbers remain important as cannabis companies work through tighter financial conditions.
Management continues emphasizing disciplined expansion and long-term profitability. This strategy could position Verano well if the cannabis market improves during the next few years. Many traders still view VRNOF as a strong marijuana penny stock candidate because of its size and market reach.
Although the cannabis sector remains volatile, Verano continues showing operational strength compared to many smaller competitors. As a result, the stock remains under close watch during May 2026.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
